DK677688A - Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne - Google Patents
Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanneInfo
- Publication number
- DK677688A DK677688A DK677688A DK677688A DK677688A DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A DK 677688 A DK677688 A DK 677688A
- Authority
- DK
- Denmark
- Prior art keywords
- human
- somatometricated
- procedures
- manufacturing
- protein substances
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4743—Insulin-like growth factor binding protein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3488587A | 1987-04-06 | 1987-04-06 | |
PCT/US1988/001042 WO1988007863A1 (en) | 1987-04-06 | 1988-03-31 | Human somatomedin carrier protein subunits and process for producing them |
Publications (2)
Publication Number | Publication Date |
---|---|
DK677688D0 DK677688D0 (da) | 1988-12-05 |
DK677688A true DK677688A (da) | 1988-12-05 |
Family
ID=21879212
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK677688A DK677688A (da) | 1987-04-06 | 1988-12-05 | Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne |
Country Status (11)
Country | Link |
---|---|
EP (2) | EP0308500B1 (ja) |
JP (1) | JP2648951B2 (ja) |
AT (1) | ATE90690T1 (ja) |
AU (1) | AU627423B2 (ja) |
CA (1) | CA1340295C (ja) |
DE (1) | DE3881801T2 (ja) |
DK (1) | DK677688A (ja) |
ES (1) | ES2058341T3 (ja) |
IL (1) | IL85983A (ja) |
WO (1) | WO1988007863A1 (ja) |
ZA (1) | ZA882407B (ja) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5973115A (en) * | 1987-05-15 | 1999-10-26 | Amgen Inc. | Method for potentiating and inhibiting insulin-like growth factor activity |
US5258287A (en) * | 1988-03-22 | 1993-11-02 | Genentech, Inc. | DNA encoding and methods of production of insulin-like growth factor binding protein BP53 |
ATE132164T1 (de) * | 1988-04-12 | 1996-01-15 | Amgen Boulder Inc | Verfahren zur steigerung und zur hemmung der wirkung eines insulinähnlichen wachstumfaktors |
US5324820A (en) * | 1988-07-15 | 1994-06-28 | Central Sydney Area Health Service | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
WO1990000569A1 (en) * | 1988-07-15 | 1990-01-25 | Central Sydney Area Health Service | Acid-labile subunit (als) of insulin-like-growth factor (igf) binding protein complex |
US6465423B1 (en) | 1988-07-15 | 2002-10-15 | Central Sydney Area Health Service | Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex |
US5187151A (en) * | 1991-02-12 | 1993-02-16 | Genentech, Inc. | Use of binding protein with igf-i as an anabolic growth promoting agent |
EP0800530A4 (en) * | 1994-07-20 | 1998-12-02 | Celtrix Pharma | IGF / IGFBP COMPLEX FOR PROMOTING BONE TRAINING AND REGULATING BONE REMODELING |
US6121416A (en) | 1997-04-04 | 2000-09-19 | Genentech, Inc. | Insulin-like growth factor agonist molecules |
US6420518B1 (en) | 1997-04-04 | 2002-07-16 | Genetech, Inc. | Insulin-like growth factor agonist molecules |
US20030069177A1 (en) | 2000-05-16 | 2003-04-10 | Genentech, Inc. | Method for treating cartilage disorders |
EP1141014B1 (en) | 1999-01-06 | 2004-12-08 | Genentech, Inc. | Insulin-like growth factor (igf) i mutant variant |
IL143834A0 (en) | 1999-01-06 | 2002-04-21 | Genentech Inc | Insulin-like growth factor (igf) i mutant variants |
CA2702192A1 (en) | 2001-03-14 | 2002-09-19 | Genentech, Inc. | Igf antagonist peptides |
US7638605B2 (en) | 2003-05-01 | 2009-12-29 | ImClone, LLC | Fully human antibodies directed against the human insulin-like growth factor-1 receptor |
PT2274978E (pt) | 2003-09-12 | 2015-07-09 | Ipsen Biopharmaceuticals Inc | Métodos para tratamento da deficiência do fator de crescimento de tipo insulina i (igf-i) |
CA2541015A1 (en) | 2003-10-03 | 2005-04-14 | Genentech, Inc. | Igf binding proteins |
CA2612449A1 (en) | 2005-06-17 | 2006-12-28 | Imclone Systems Incorporated | Receptor antagonists for treatment of metastatic bone cancer |
CN101484587B (zh) | 2006-02-03 | 2014-02-12 | 英克隆有限责任公司 | Igf-ir拮抗剂作为辅药用于前列腺癌的治疗 |
KR20200097679A (ko) | 2017-09-11 | 2020-08-19 | 샤이어 휴먼 지네틱 테라피즈 인크. | 만성 폐 질환 치료를 위한 방법 및 조성물 |
MX2023004426A (es) | 2020-10-19 | 2023-08-04 | Oak Hill Bio Ltd | Composiciones adecuadas para su uso en neonatos. |
WO2023139115A1 (en) | 2022-01-19 | 2023-07-27 | Oak Hill Bio Limited | Compositions and methods for reducing oxidation of igf‐1/igfbp |
WO2023242439A1 (en) | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Vascular stabilisation (preterm infants) |
WO2023242442A1 (en) | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Method of maturing/differentiating neurons and/or modulating the vagus nerve |
WO2023242440A1 (en) | 2022-06-17 | 2023-12-21 | Oak Hill Bio Limited | Treament of lungs in infants |
-
1988
- 1988-03-31 WO PCT/US1988/001042 patent/WO1988007863A1/en active IP Right Grant
- 1988-03-31 EP EP88904042A patent/EP0308500B1/en not_active Expired - Lifetime
- 1988-03-31 AU AU17020/88A patent/AU627423B2/en not_active Ceased
- 1988-03-31 DE DE88904042T patent/DE3881801T2/de not_active Expired - Fee Related
- 1988-03-31 ES ES88904042T patent/ES2058341T3/es not_active Expired - Lifetime
- 1988-03-31 JP JP63503623A patent/JP2648951B2/ja not_active Expired - Lifetime
- 1988-03-31 AT AT88904042T patent/ATE90690T1/de active
- 1988-04-05 CA CA000563309A patent/CA1340295C/en not_active Expired - Fee Related
- 1988-04-05 IL IL8598388A patent/IL85983A/en unknown
- 1988-04-06 EP EP88303041A patent/EP0294021A1/en active Pending
- 1988-04-07 ZA ZA882407A patent/ZA882407B/xx unknown
- 1988-12-05 DK DK677688A patent/DK677688A/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP0294021A1 (en) | 1988-12-07 |
JP2648951B2 (ja) | 1997-09-03 |
ES2058341T3 (es) | 1994-11-01 |
IL85983A (en) | 1994-10-07 |
EP0308500B1 (en) | 1993-06-16 |
EP0308500A1 (en) | 1989-03-29 |
ZA882407B (en) | 1988-09-28 |
WO1988007863A1 (en) | 1988-10-20 |
CA1340295C (en) | 1998-12-29 |
AU627423B2 (en) | 1992-08-27 |
AU1702088A (en) | 1988-11-04 |
JPH01502986A (ja) | 1989-10-12 |
ATE90690T1 (de) | 1993-07-15 |
DK677688D0 (da) | 1988-12-05 |
DE3881801D1 (de) | 1993-07-22 |
DE3881801T2 (de) | 1993-12-23 |
IL85983A0 (en) | 1988-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK677688A (da) | Humane somatomedinbaererproteinunderenheder og fremgangsmaade til fremstilling af saadanne | |
DK95291D0 (da) | Rekombinante dna-molekyler | |
DK564989D0 (da) | Bindingsproteiner | |
US5043429B1 (en) | Protein fragments containing factor VIII binding domain of von willebrand factor | |
WO1994004691A3 (en) | Dimer and multimer forms of single chain polypeptides | |
DK643087A (da) | Fremgangsmaade til isomerisering af en kulbrintefoedestroem | |
IL85878A0 (en) | Anticoagulant proteins,dna coding for them,processes for preparing them,pharmaceutical compositions containing them,monoclonal antibodies against such proteins and hybrid cell lines which secrete these antibodies | |
DE69000338D1 (de) | Expressionssystem zur herstellung von chimaeren monoklonalen antikoerpern. | |
FI97299C (fi) | Menetelmä kimeerisen transformoivan beta-kasvutekijän valmistamiseksi | |
FI953525A (fi) | Kemiallinen syntetointimenetelmä fibronektiiniä sitovan proteiinin tai polypeptidin valmistamiseksi | |
DE3581288D1 (de) | Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen. | |
ATE186781T1 (de) | Verfahren zur herstellung von testelementen | |
HUT55800A (en) | Process for producing anticoagulant peptides | |
AU576508B2 (en) | Sythetic peptides antigenically corresponding to brain specific proteinoids | |
DE3881101D1 (de) | Monoklonal-antikoerper und methode fuer die bereitung von hybridoma, produzierend diese antikoerper. | |
DK142147B (da) | Fremgangsmaade til rensning af serumproteinkonjugater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AHB | Application shelved due to non-payment |